首页> 外文期刊>Leukemia Research Reports >Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice
【24h】

Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice

机译:急性髓性白血病,肝脏浸润呈现为阻塞性黄疸

获取原文
       

摘要

We present the case of a 55-year-old woman who presented with laboratory studies concerning for acute myeloid leukemia (AML) as well as obstructive cholestasis. In similar previously reported cases, concerns of chemotherapy toxicity exacerbated by liver dysfunction or concerns of untreated, concurrent cholecystitis in a neutropenic patient often delay initiation of chemotherapy for full medical workup. At admission, our patient was started on the cytoreductive agent hydroxyurea. By day 10 of her medical workup, her liver function had improved with total bilirubin levels normalizing. At that time, full-dose 7?+?3 induction with cytarabine and daunorubicin was then initiated.
机译:我们展示了一个55岁女性的案例,他提出了关于急性髓性白血病(AML)的实验室研究以及阻塞性胆汁淤积。 在类似先前报道的病例中,通过肝功能障碍加剧的化疗毒性的疑虑或未治疗的并发胆囊炎在中性患者中的担忧通常会延迟化疗开始进行全面的医疗疗法。 在入院时,我们的患者开始在细胞渗透剂羟基脲开始。 在她的医疗余处第10天,她的肝功能随着胆红素水平的总结而得到改善。 当时,然后引发全剂量7?3 +α+ 3诱导含有氨基甲嘧啶和Daunorubicin。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号